CD274 and neoplasm: To facilitate intratumoral T cell infiltration and drug penetration, Wang's group developed a pH responsive nanoparticle to co-deliver TGF-β receptor inhibitor (LY2157299) and siRNA targeting PD-L1 (siPD-L1) for the combination of tumor ECM modulation and antitumor immunotherapy [86].